Recent developments of hydrazide/hydrazone derivatives and their analogs as anticonvulsant agents in animal models V Angelova, V Karabeliov, PA Andreeva‐Gateva, J Tchekalarova Drug development research 77 (7), 379-392, 2016 | 70 | 2016 |
Epigenetic alterations in patients with type 2 diabetes mellitus S Karachanak-Yankova, R Dimova, D Nikolova, D Nesheva, ... Balkan Journal of Medical Genetics 18 (2), 15-24, 2015 | 44 | 2015 |
Discovery of novel indole-based aroylhydrazones as anticonvulsants: Pharmacophore-based design VT Angelova, M Rangelov, N Todorova, M Dangalov, P Andreeva-Gateva, ... Bioorganic Chemistry 90, 103028, 2019 | 28 | 2019 |
Antioxidant effect of alpha-lipoic acid in 6-hydroxydopamine unilateral intrastriatal injected rats P Andreeva-Gateva, L Traikov, Z Sabit, D Bakalov, ... Antioxidants 9 (2), 122, 2020 | 21 | 2020 |
Atherogenic index of plasma, castelli risk indexes and leptin/adiponectin ratio in women with metabolic syndrome DI Koleva, PA Andreeva-Gateva, MM Orbetzova, IB Atanassova, ... International Journal of Pharmaceutical and Medical Research 3 (5), 12-16, 2015 | 19 | 2015 |
Antioxidant parameters in metabolic syndrome--a dynamic evaluation during oral glucose tolerance test P Andreeva-Gateva, D Popova, V Orbetsova Vutreshni Bolesti 33 (2-3), 48-53, 2001 | 18 | 2001 |
Type 2 diabetes mellitus and cardiovascular risk; what the pharmacotherapy can change through the epigenetics PA Andreeva–Gateva, ID Mihaleva, II Dimova Postgraduate medicine 132 (2), 109-125, 2020 | 13 | 2020 |
Synthetic cannabimimetics in Bulgaria 2010–2013 PA Andreeva-Gateva, VH Nankova, VT Angelova, TN Gatev Drug and alcohol dependence 157, 200-204, 2015 | 13 | 2015 |
Anticonvulsant activity of newly synthesized 2H-chromene based hydrazones in ICR mice VT Angelova, PA Andreeva-Gateva, NG Vassilev, ... Compt Rend Acad Bulg Sci 69, 513-520, 2016 | 12 | 2016 |
In vitro and in silico evaluation of chromene based aroyl hydrazones as anticonvulsant agents VT Angelova, Y Voynikov, P Andreeva-Gateva, S Surcheva, N Vassilev, ... Medicinal Chemistry Research 26, 1884-1896, 2017 | 10 | 2017 |
The place of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease: a narrative review PA Andreeva-Gateva, E Stamenova, T Gatev Postgraduate Medicine 128 (5), 474-484, 2016 | 9 | 2016 |
Effect of zinc on the activity of Cu/Zn superoxide dismutase and lipid profile in Wistar rats. AA Dimitrova, DS Strashimirov, AL Russeva, PA Andreeva-Gateva, ... Folia Medica 47 (1), 42-46, 2005 | 9 | 2005 |
Evaluation of neurobiological and antioxidant effects of novel melatonin analogs in mice J Tchekalarova, N Ivanova, Z Nenchovska, R Tzoneva, T Stoyanova, ... Saudi Pharmaceutical Journal 28 (12), 1566-1579, 2020 | 8 | 2020 |
Evaluation of the anticonvulsant effect of novel melatonin derivatives in the intravenous pentylenetetrazol seizure test in mice J Tchekalarova, VT Angelova, N Todorova, P Andreeva-Gateva, ... European Journal of Pharmacology 863, 172684, 2019 | 8 | 2019 |
Insulin resistance and oxidative stress P Andreeva-Gateva Vutreshni Bolesti 31 (4), 9-19, 1999 | 8 | 1999 |
The place of trabectedin in the treatment of soft tissue sarcoma: an umbrella review of the level one evidence P Andreeva-Gateva, S Chakar Expert Opinion on Orphan Drugs 7 (3), 105-115, 2019 | 7 | 2019 |
Analgesic activity of some aroylhydrazone-based molecular hybrids with antiseizure activity: in vivo and in silico evaluations S Marchev, P Andreeva-Gateva, R Tzoneva, S Surcheva, A Tzonev, ... Biotechnology & Biotechnological Equipment 33 (1), 98-107, 2019 | 6 | 2019 |
Differentiation of obese patients at moderate or higher Findrisc score based on their atherogenic index PA Andreeva-Gateva, P Konsulova, M Orbetzova, R Georgieva-Nikolova, ... Postgraduate Medicine 128 (8), 790-796, 2016 | 6 | 2016 |
Cluster analysis of the components of the metabolic syndrome in subjects with an increased risk for diabetes mellitus type 2 PA Andreeva-Gateva, VD Simeonov, RT Georrgieva-Nikolova, ... Endocrinologya 19, 168-185, 2014 | 6 | 2014 |
Antioxidant vitamins--significance for preventing cardiovascular diseases. Part 1. Oxidized low-density lipoproteins and atherosclerosis; antioxidant dietary supplementation … P Andreeva-Gateva Vutreshni Bolesti 32 (3), 11-18, 2000 | 5 | 2000 |